Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Herbert, FR

Corentin Herbert, Paris FR

Patent application numberDescriptionPublished
20110150903FGF-R4 RECEPTOR-SPECIFIC ANTAGONISTS - The present invention relates to FGF-R4 receptor-specific antagonist molecules enabling the inhibition of the activity of said receptor. Said antagonists are, particularly, FGF-R4-specific antibodies enabling the inhibition of the activity of said receptor. The present invention also relates to the therapeutic use of said antibodies, particularly in the field of angiogenesis and in the treatment of certain types of cancer.06-23-2011

Fabien Herbert, Lille FR

Patent application numberDescriptionPublished
20120040447MAGNETIC IMMUNODIAGNOSTIC METHOD FOR THE DEMONSTRATION OF ANTIBODY/ANTIGEN COMPLEXES ESPECIALLY OF BLOOD GROUPS - The invention relates to a magnetic immunodiagnostic method for the demonstration of antibody-antigen complexes. One such method involves the research and/or identification of antibodies or antigens, preferably anti-antigen antibodies or antigens of a blood group, and comprises a suspension of magnetic particles coated with antigens that can be carried by cells such as erythrocytes. The invention also relates to a device and a kit for carrying out one such method.02-16-2012

Fabien Herbert, Neuville Saint Remi FR

Patent application numberDescriptionPublished
20090269776Magnetic Immunodiagnostic Method for the Demonstration of Antibody/Antigen Complexes especially of blood groups - The invention relates to a magnetic immunodiagnostic method for the demonstration of antibody-antigen complexes. One such method involves the research and/or identification of antibodies or antigens, preferably anti-antigen antibodies or antigens of a blood group, and comprises a suspension of magnetic particles coated with antigens that can be carried by cells such as erythrocytes. The invention also relates to a device and a kit for carrying out one such method.10-29-2009

Jean Marc Herbert, Tournefeuille FR

Patent application numberDescriptionPublished
20090023770Novel 1,2,3-Substituted Indolizine Derivatives, Inhibitors of FGFs, Method for Preparing Them and Pharmaceutical Compositions Containing Them - The present invention relates to novel 1,2,3-substituted indolizine derivative which are inhibitors of fibroblast growth factors, to methods or preparing such derivatives, to pharmaceutical compositions comprising such derivatives, and to methods of treatment comprising such derivatives.01-22-2009
20090215755USE OF A PYRAZOLE DERIVATIVE FOR PREPARING MEDICINAL PRODUCTS THAT ARE USEFUL IN THE PREVENTION AND TREATMENT OF DYSLIPIDAEMIAS AND OF DISEASES RELATED TO DYSLIPIDAEMIAS AND/OR TO OBESITY - Use of a pyrazole-derived compound that is an antagonist for cannabinoid CB08-27-2009
20100279960BIOTINYLATED HEXADECASACCHARIDES, PREPARATION AND USE THEREOF - The invention concerns novel biotinylated hexadecasaccharides of general formula (I) wherein: Biot is a biotin derivative; R, R11-04-2010
20110144042Novel Polysaccharides with Antithrombotic Activity Comprising at Least One Covalent Bond with Biotin or a Biotin Derivative - The present invention relates to novel synthetic polysaccharides with antithrombotic activity exhibiting at least one covalent bond with biotin or a biotin derivative and to a process employing avidin or streptavidin which makes it possible to neutralize these polysaccharides.06-16-2011
20110251194ANTINEOPLASTIC DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF - The disclosure concerns heterobicyclic compounds of general formula (I) and acid addition salts, hydrates and solvates thereof, as well as enantiomers, diastereoisomers and mixtures thereof. Methods for preparing the compounds, pharmaceutical compositions, and methods of treatment also are disclosed.10-13-2011

Patent applications by Jean Marc Herbert, Tournefeuille FR

Michel Herbert, Marseille FR

Patent application numberDescriptionPublished
20090035758Method of Measurement of Micronucleated Erythrocyte Populations - A method of measuring micronucleated erythrocyte populations is disclosed. The method includes contacting a sample containing erythrocyte populations with a fluorescently labeled antibody specific to immature erythrocytes among erythrocyte populations; adding an aqueous permeation reagent to the sample and incubating the formed permeation sample mixture for an incubation time sufficient to allow the permeation reagent to render cellular membrane of the erythrocyte populations permeable to RNase and dye; adding a RNase reagent to degrade RNA and to inhibit further reaction of permeation reagent; adding a fluorescent nucleic acid dye reagent to stain DNA representing micronuclei in the erythrocyte populations; performing light scatter and fluorescence measurements of the final sample mixture on a flow cytometer; differentiating micronucleated erythrocyte populations from other cell types; and reporting the micronucleated erythrocyte populations of the sample. The method avoids ultracold fixation, centrifugation, and washing cells in sample preparation.02-05-2009

Patrick Herbert, Bourguebus FR

Patent application numberDescriptionPublished
20080255648Accessory for Muscle Maintenance and/or Muscle Development - The invention concerns an accessory (10-16-2008
20080255649Electrode Module for Muscle Maintenance and/or Muscle Development - The invention concerns an electrode module (10-16-2008

Tanguy Herbert, Hirel FR

Patent application numberDescriptionPublished
20090027200Electronic Wireless Detecting and Alarm Device Allowing Monitoring Of Fluid Level in a Tank or Cistern - The invention concerns an electronic device for monitoring a reservoir (01-29-2009